Close

Choose your country

Or view all businesses for sale

Worldwide

Advertisement

High Profits Pain Treatment Center - Semi-Absentee For Sale

Washington County, Oregon, US
Asking Price:
$2,000,000
Sales Revenue:
$3,600,000
Cash Flow:
Undisclosed

High Profits Pain Treatment Center - Semi-Absentee

​This alternative health treatment franchise offers nonsurgical regenerative treatments that relieve joint pain, arthritis, and injuries—without surgery, steroids, or addictive medications. They use non-surgical injections to restore damaged tissue, decrease pain, and increase quality of life. The treatment is designed to be a long-term fix and keep patients out of surgery, away from toxic steroid injections, and off addictive pain medications. The business provides concierge-style treatments using advanced techniques like platelet-rich plasma (PRP), laser therapy, and biologics such as alpha-2-macroglobulin (A2M) and bone marrow aspirate concentrate (BMAC)—all designed to restore function and reduce pain long-term.

This is a four-unit expansion that covers the entire market area, including parts of Washington. Each clinic is open one day per week and requires 4 employees: the front desk, the CMA/phlebotomist, the PA/NP, and an office manager. The new owner will not be required to have prior medical training or experience. The ideal new owner will have a strong management background.

In 2024, the market for regenerative medicine was estimated to be worth $35 billion. By 2032, the market for regenerative medicine is expected to soar to $615 billion by 2028.

This is the perfect business for a qualified operator/investor looking to join a first-class established franchise system and to compress time by purchasing a protected, multi-unit territory expansion.

Property Information

Real Estate:

Lease

Location:

Portland, OR
Washington County

Premises Details:

2,000 square feet second generation medical office space.

Size in square feet:
2,000

Business Operation

Expansion Potential:

This is a recession-proof and essential business that operates in the heart of the regenerative medicine market, which is projected to reach $615 billion by 2028.

Reasons for selling:

Expansion

Years established:
8 Years

Other Information

Support & training:

The owner is willing to train/assist the new owner.